Your browser doesn't support javascript.
loading
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines.
Maura, F; Petljak, M; Lionetti, M; Cifola, I; Liang, W; Pinatel, E; Alexandrov, L B; Fullam, A; Martincorena, I; Dawson, K J; Angelopoulos, N; Samur, M K; Szalat, R; Zamora, J; Tarpey, P; Davies, H; Corradini, P; Anderson, K C; Minvielle, S; Neri, A; Avet-Loiseau, H; Keats, J; Campbell, P J; Munshi, N C; Bolli, N.
Afiliação
  • Maura F; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Petljak M; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
  • Lionetti M; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
  • Cifola I; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Liang W; Hematology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Pinatel E; Institute for Biomedical Technologies, National Research Council, Milan, Italy.
  • Alexandrov LB; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Fullam A; Institute for Biomedical Technologies, National Research Council, Milan, Italy.
  • Martincorena I; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.
  • Dawson KJ; Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
  • Angelopoulos N; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Samur MK; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
  • Szalat R; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
  • Zamora J; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
  • Tarpey P; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
  • Davies H; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Corradini P; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Anderson KC; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
  • Minvielle S; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
  • Neri A; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
  • Avet-Loiseau H; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Keats J; Department of Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Campbell PJ; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Munshi NC; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France and CHU de Nantes, Nantes, France.
  • Bolli N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Leukemia ; 32(4): 1044-1048, 2018 04.
Article em En | MEDLINE | ID: mdl-29209044
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraproteinemias / Leucemia Plasmocitária / Desaminases APOBEC / Mieloma Múltiplo / Mutação Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraproteinemias / Leucemia Plasmocitária / Desaminases APOBEC / Mieloma Múltiplo / Mutação Idioma: En Ano de publicação: 2018 Tipo de documento: Article